Kyuhyun Lee

Texas Department of Transportation — United States

Medicine · Health Sciences

22h-index2.0kcitations95works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(14), Monoclonal and Polyclonal Antibodies Research(14), Urban Transport and Accessibility(8), Advancements in Semiconductor Devices and Circuit Design(8), Semiconductor materials and devices(7)

Publications95 total

Willingness to share self-driving on-demand transportation services with a focus on marginalised populations in the U.S.
Transportmetrica A Transport Science·2025
Who rides the bus in small cities in the U.S. Midwest?
Journal of Public Transportation·2025· 1 citedOpen Access
E-bikes Toward Inclusive Mobility: A Literature Review of Perceptions, Concerns, and Barriers
Transportation Research Interdisciplinary Perspectives·2023· 33 citedOpen Access
Data from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary figure 2 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary table 2 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary method from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary table 1 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary figure 1 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary method from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary figure 2 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Data from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary table 2 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary table 1 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary figure 1 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Hospitalisation During Lockdown – Patients' Bed's-Eye View
Heart Lung and Circulation·2022
Very Elderly Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention
Heart Lung and Circulation·2021· 5 cited
A Study on The Relationship Between Intraoperative Neuromonitoring and Hemoglobin Changes
International journal of advanced smart convergence·2020Open Access
A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants
PLoS ONE·2020· 9 citedOpen Access
Strava Metro data for bicycle monitoring: a literature review
Transport Reviews·2020· 106 cited
page 1 of 5Next →

Frequent Co-authors

Seungwu Han(6), Ipek N. Sener(6), Kinam Kim(5), Sun Dong Yoo(4), Dongsun Yoo(4), Wonseok Jeong(4), Eui‐Cheol Jo(4), Richard P. Bagozzi(3), Yangmi Lim(3), Jonghwa Won(3), Yun-Seok Rhee(3), Chun‐Woong Park(3), Eun‐Seok Park(3), Jae‐Young Jung(2), Sang-Heon Lee(2), Jong Woo Park(2), Sang‐Cheol Chi(2), Eun-Hee Kang(2), Hun Jun(2), Kwang-Hoon Oh(2)